{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:07:52Z","timestamp":1784693272130,"version":"3.55.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.autrev.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T13:15:54Z","timestamp":1460207754000},"page":"809-819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Vogt\u2013Koyanagi\u2013Harada syndrome: Perspectives for immunogenetics, multimodal imaging, and therapeutic options"],"prefix":"10.1016","volume":"15","author":[{"given":"Sukhum","family":"Silpa-archa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narumol","family":"Silpa-archa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine M.","family":"Preble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2-3","key":"10.1016\/j.autrev.2016.04.001_bb0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10792-007-9083-4","article-title":"Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan","volume":"27","author":"Herbort","year":"2007","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.autrev.2016.04.001_bb0010","first-page":"1","article-title":"Pattern of Uveitis in a Referral Ophthalmology Center in the Central District of Thailand","volume":"11","author":"Silpa-Archa","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.autrev.2016.04.001_bb0015","doi-asserted-by":"crossref","first-page":"157803","DOI":"10.1155\/2014\/157803","article-title":"Gender differences in vogt-koyanagi-harada disease and sympathetic ophthalmia","volume":"2014","author":"Wang","year":"2014","journal-title":"J Ophthalmol"},{"issue":"7","key":"10.1016\/j.autrev.2016.04.001_bb0020","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/IAE.0b013e3181c96a87","article-title":"Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India","volume":"30","author":"Martin","year":"2010","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1076\/ocii.6.3.155.4041","article-title":"Vogt-Koyanagi-Harada syndrome in children","volume":"6","author":"Rathinam","year":"1998","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/112067210601600130","article-title":"Vogt-Koyanagi-Harada associated with diabetes mellitus and celiac disease in a 3-year-old girl","volume":"16","author":"Al Hemidan","year":"2006","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/ceo.12512","article-title":"Vogt-Koyanagi-Harada disease in 3-year-old boy","volume":"43","author":"Takada","year":"2015","journal-title":"Clin Experiment Ophthalmol"},{"issue":"Pt 2","key":"10.1016\/j.autrev.2016.04.001_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/eye.1997.54","article-title":"Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome","volume":"11","author":"Rao","year":"1997","journal-title":"Eye (Lond)"},{"issue":"11","key":"10.1016\/j.autrev.2016.04.001_bb0045","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/bjo.80.11.1002","article-title":"Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease","volume":"80","author":"Norose","year":"1996","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.autrev.2016.04.001_bb0050","first-page":"2004","article-title":"Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease","volume":"42","author":"Gocho","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0055","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaci.2007.01.010","article-title":"IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease","volume":"119","author":"Chi","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2016.04.001_bb0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","article-title":"Th1 and Th17 cells: adversaries and collaborators","volume":"1183","author":"Damsker","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bjophthalmol-2015-307366","article-title":"Investigation of the association of Vogt-Koyanagi-Harada syndrome with IL23R-C1orf141 in Han Chinese Singaporean and ADO-ZNF365-EGR2 in Thai","volume":"100","author":"Cao","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.autrev.2016.04.001_bb0075","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1167\/iovs.12-9863","article-title":"Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease","volume":"53","author":"Wang","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0080","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ophtha.2014.09.025","article-title":"Genetic variations of IL17F and IL23A show associations with Behcet's disease and Vogt-Koyanagi-Harada syndrome","volume":"122","author":"Hou","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.autrev.2016.04.001_bb0085","first-page":"1537","article-title":"Monocyte chemoattractant protein (MCP)-1 -2518 A\/G SNP in Chinese Han patients with VKH syndrome","volume":"15","author":"Hou","year":"2009","journal-title":"Mol Vis"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2008.01.004","article-title":"Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome","volume":"127","author":"Du","year":"2008","journal-title":"Clin Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2016.04.001_bb0095","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1167\/iovs.13-12187","article-title":"MIF gene polymorphisms confer susceptibility to Vogt-Koyanagi-Harada syndrome in a Han Chinese population","volume":"54","author":"Zhang","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.autrev.2016.04.001_bb0100","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1136\/bjophthalmol-2014-305596","article-title":"High C4 gene copy numbers protects against Vogt-Koyanagi-Harada syndrome in Chinese Han","volume":"98","author":"Hou","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.autrev.2016.04.001_bb0105","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1167\/iovs.08-1793","article-title":"Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome","volume":"49","author":"Chen","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-3083.2010.02401.x","article-title":"IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome","volume":"72","author":"Commodaro","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2016.04.001_bb0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12348-014-0020-1","article-title":"Influence of molecular genetics in Vogt-Koyanagi-Harada disease","volume":"4","author":"Ng","year":"2014","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.autrev.2016.04.001_bb0120","first-page":"353","article-title":"A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients","volume":"16","author":"Tiercy","year":"2010","journal-title":"Mol Vis"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJM197607152950322","article-title":"Letter: HLA and Vogt-Koyanagh-Harada syndrome","volume":"295","author":"Tagawa","year":"1976","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.autrev.2016.04.001_bb0130","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0161-6420(90)32446-6","article-title":"HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia","volume":"97","author":"Davis","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.autrev.2016.04.001_bb0135","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1038\/srep06887","article-title":"Association of HLA-DR4\/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: a systematic review and meta-analysis","volume":"4","author":"Shi","year":"2014","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0140","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1167\/iovs.05-1547","article-title":"Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens","volume":"47","author":"Sugita","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.autrev.2016.04.001_bb0145","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1167\/iovs.04-1273","article-title":"T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis","volume":"46","author":"Damico","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0150","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo.2005.086520","article-title":"Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease","volume":"90","author":"Otani","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0155","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00006982-199616020-00013","article-title":"Detection of Epstein-Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-Koyanagi-Harada syndrome","volume":"16","author":"Bassili","year":"1996","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.autrev.2016.04.001_bb0160","first-page":"289","article-title":"High inducibility of Epstein-Barr virus replication in B lymphocytes in Vogt-Koyanagi-Harada disease","volume":"103","author":"Minoda","year":"1999","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"2-3","key":"10.1016\/j.autrev.2016.04.001_bb0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10792-006-9020-y","article-title":"Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease","volume":"27","author":"Sugita","year":"2007","journal-title":"Int Ophthalmol"},{"issue":"11","key":"10.1016\/j.autrev.2016.04.001_bb0170","first-page":"953","article-title":"Ocular infiltrating CD 4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens","volume":"112","author":"Sugita","year":"2008","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0175","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0161-6420(99)90129-X","article-title":"Vogt-Koyanagi-Harada syndrome after cutaneous injury","volume":"106","author":"Rathinam","year":"1999","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0180","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.iio.0000155904.87679.0c","article-title":"Vogt-Koyanagi-Harada disease","volume":"45","author":"Rajendram","year":"2005","journal-title":"Int Ophthalmol Clin"},{"issue":"4","key":"10.1016\/j.autrev.2016.04.001_bb0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0039-6257(05)80105-5","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"39","author":"Moorthy","year":"1995","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0195","first-page":"334","article-title":"Clinical studies of Vogt-Koyanagi-Harada's disease","volume":"32","author":"Ohno","year":"1988","journal-title":"Jpn J Ophthalmol"},{"issue":"10","key":"10.1016\/j.autrev.2016.04.001_bb0200","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1097\/IAE.0b013e318256205a","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease","volume":"32","author":"Nakayama","year":"2012","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0205","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/IAE.0b013e3182083beb","article-title":"Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease","volume":"31","author":"Fong","year":"2011","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.autrev.2016.04.001_bb0210","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/02713680802233968","article-title":"Vogt-koyanagi-harada syndrome","volume":"33","author":"Fang","year":"2008","journal-title":"Curr Eye Res"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0215","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ajo.2005.01.046","article-title":"Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada's disease","volume":"139","author":"Kitamura","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0220","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ophtha.2009.08.030","article-title":"Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease","volume":"117","author":"Rao","year":"2010","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0225","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ophtha.2006.07.040","article-title":"Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients","volume":"114","author":"Yang","year":"2007","journal-title":"Ophthalmology"},{"issue":"2-3","key":"10.1016\/j.autrev.2016.04.001_bb0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10792-006-9009-6","article-title":"Spectrum of Vogt-Koyanagi-Harada disease in Singapore","volume":"27","author":"Chee","year":"2007","journal-title":"Int Ophthalmol"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10792-007-9144-8","article-title":"Posterior segment recurrences in Vogt-Koyanagi-Harada disease","volume":"28","author":"Sachdev","year":"2008","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0240","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0161-6420(00)00428-0","article-title":"The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease","volume":"108","author":"Bouchenaki","year":"2001","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0245","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ajo.2007.10.012","article-title":"Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease","volume":"145","author":"Bacsal","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0250","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1111\/aos.12640","article-title":"Late posterior segment relapses in a series of Vogt-Koyanagi-Harada disease","volume":"93","author":"Errera","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1869-5760-4-6","article-title":"Choroidal bulging in patients with Vogt-Koyanagi-Harada disease in the non-acute uveitic stage","volume":"4","author":"Sakata","year":"2014","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"4","key":"10.1016\/j.autrev.2016.04.001_bb0260","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/bjophthalmol-2014-306439","article-title":"Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease","volume":"100","author":"Tagawa","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2016.04.001_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09273948.2015.1025984","article-title":"Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center","volume":"23","author":"Arevalo","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000356386","article-title":"Characteristics and prognosis of hearing loss associated with Vogt-Koyanagi-Harada disease","volume":"19","author":"Morita","year":"2014","journal-title":"Audiol Neurootol"},{"issue":"4","key":"10.1016\/j.autrev.2016.04.001_bb0275","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00016489.2013.868604","article-title":"Audiovestibular findings in patients with Vogt-Koyanagi-Harada disease","volume":"134","author":"Noguchi","year":"2014","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0280","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archopthalmol.2011.1520","article-title":"Reversal of poliosis and vitiligo following Vogt-Koyanagi-Harada disease","volume":"130","author":"Tabbara","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0285","first-page":"160","article-title":"Clinical practice. Vitiligo","volume":"360","author":"Taieb","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0290","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006982-199111030-00001","article-title":"Variations in clinical features of the Vogt-Koyanagi-Harada syndrome","volume":"11","author":"Beniz","year":"1991","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0295","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0002-9394(77)90142-8","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"83","author":"Ohno","year":"1977","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2016.04.001_bb0300","first-page":"9","article-title":"Vogt-Koyanagi-Harada disease","volume":"22","author":"Sugiura","year":"1978","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0305","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10384-004-0165-9","article-title":"Application of revised diagnostic criteria for vogt-koyanagi-harada disease in Japanese patients","volume":"49","author":"Yamaki","year":"2005","journal-title":"Jpn J Ophthalmol"},{"issue":"2-3","key":"10.1016\/j.autrev.2016.04.001_bb0310","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10792-007-9044-y","article-title":"Utility of lumbar puncture in diagnosis of Vogt-Koyanagi-Harada disease","volume":"27","author":"Tsai","year":"2007","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0315","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0002-9394(81)90286-5","article-title":"Vogt-Koyanagi-Harada syndrome with focal neurologic signs","volume":"91","author":"Lubin","year":"1981","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0320","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF02335510","article-title":"Vogt-Koyanagi-Harada syndrome: clinical and instrumental contribution","volume":"12","author":"Trebini","year":"1991","journal-title":"Ital J Neurol Sci"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0325","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/ICU.0000000000000206","article-title":"Vogt-Koyanagi-Harada disease","volume":"26","author":"Burkholder","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.autrev.2016.04.001_bb0330","series-title":"Diagnosis and treatment of uveitis","author":"Foster","year":"2013"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0335","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1017\/S0022215110001817","article-title":"Auditory and vestibular manifestations of Vogt-Koyanagi-Harada disease","volume":"125","author":"Al Dousary","year":"2011","journal-title":"J Laryngol Otol"},{"issue":"10","key":"10.1016\/j.autrev.2016.04.001_bb0340","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.mlg.0000234946.31603.fe","article-title":"Sensorineural hearing loss in Vogt-Koyanagi-Harada syndrome","volume":"116","author":"Ondrey","year":"2006","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.autrev.2016.04.001_bb0345","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000276843","article-title":"Clinical study of the role of melanocytes in the inner ear of patients with Harada's disease","volume":"58","author":"Kimura","year":"1996","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"9","key":"10.1016\/j.autrev.2016.04.001_bb0350","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/MAO.0000000000000353","article-title":"Successful cochlear implantation in a case of Vogt-Koyanagi-Harada disease","volume":"35","author":"Sydlowski","year":"2014","journal-title":"Otol Neurotol"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0355","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1017\/S0022215106000405","article-title":"Deafness in Vogt-Koyanagi-Harada syndrome","volume":"120","author":"Sil","year":"2006","journal-title":"J Laryngol Otol"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10792-015-0073-7","article-title":"Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment","volume":"36","author":"Attia","year":"2016","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.autrev.2016.04.001_bb0365","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/IIO.0b013e31826908fb","article-title":"Imaging in the diagnosis and management of Vogt-Koyanagi-Harada disease","volume":"52","author":"Jap","year":"2012","journal-title":"Int Ophthalmol Clin"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0370","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0039-6257(88)90093-8","article-title":"Posterior scleritis","volume":"32","author":"Benson","year":"1988","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"10.1016\/j.autrev.2016.04.001_bb0375","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archopht.1990.01070120069031","article-title":"Echographic features of the Vogt-Koyanagi-Harada syndrome","volume":"108","author":"Forster","year":"1990","journal-title":"Arch Ophthalmol"},{"issue":"2-3","key":"10.1016\/j.autrev.2016.04.001_bb0380","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10792-006-9024-7","article-title":"Retinal fluorescein and indocyanine green angiography and optical coherence tomography in successive stages of Vogt-Koyanagi-Harada disease","volume":"27","author":"Fardeau","year":"2007","journal-title":"Int Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0385","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ajo.2007.04.007","article-title":"Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease","volume":"144","author":"Yamaguchi","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0390","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bjophthalmol-2012-302089","article-title":"Enhanced depth imaging optical coherence tomography in long-standing Vogt-Koyanagi-Harada disease","volume":"97","author":"da Silva","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0395","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/IAE.0000000000000312","article-title":"Choroidal granulomas visualized by enhanced depth imaging optical coherence tomography","volume":"35","author":"Invernizzi","year":"2015","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0400","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/IAE.0b013e3181c5970d","article-title":"Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings","volume":"30","author":"Vasconcelos-Santos","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.autrev.2016.04.001_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09273948.2015.1057600","article-title":"Changes in Scleral Architecture in Chronic Vogt-Koyanagi-Harada Disease","volume":"8","author":"Harada","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0410","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/IAE.0000000000000728","article-title":"Retinal pigment epithelium undulations in acute stage of Vogt-Koyanagi-Harada disease: Biomarker for Functional Outcomes After High-Dose Steroid Therapy","volume":"36","author":"Hashizume","year":"2016","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0415","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3341\/kjo.2015.29.6.389","article-title":"Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy","volume":"29","author":"Shin","year":"2015","journal-title":"Korean J Ophthalmol"},{"issue":"11","key":"10.1016\/j.autrev.2016.04.001_bb0420","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1136\/bjo.2009.164665","article-title":"Blue light and near-infrared fundus autofluorescence in acute Vogt-Koyanagi-Harada disease","volume":"94","author":"Koizumi","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0425","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ajo.2010.06.029","article-title":"The prognostic value of angiography in Vogt-Koyanagi-Harada disease","volume":"150","author":"Chee","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"2-3","key":"10.1016\/j.autrev.2016.04.001_bb0430","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10792-007-9060-y","article-title":"Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up","volume":"27","author":"Herbort","year":"2007","journal-title":"Int Ophthalmol"},{"issue":"12","key":"10.1016\/j.autrev.2016.04.001_bb0435","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/bjo.86.12.1374","article-title":"Ultrasound biomicroscopic study of ciliary body changes in the post-treatment phase of Vogt-Koyanagi-Harada disease","volume":"86","author":"Wada","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.autrev.2016.04.001_bb0440","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/09273941003693042","article-title":"Morphologic changes in the anterior segment in patients with initial-onset or recurrent Vogt-Koyanagi-Harada disease","volume":"18","author":"Ahn","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0445","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9394(14)75078-0","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"90","author":"Snyder","year":"1980","journal-title":"Am J Ophthalmol"},{"issue":"2-3","key":"10.1016\/j.autrev.2016.04.001_bb0450","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10792-006-9021-x","article-title":"Vogt-Koyanagi-Harada disease diagnostic criteria","volume":"27","author":"Rao","year":"2007","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0455","first-page":"148","article-title":"Prognostic factors for Vogt-Koyanagi-Harada disease","volume":"66","author":"Sheu","year":"2003","journal-title":"J Chin Med Assoc"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0460","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0002-9394(01)00937-0","article-title":"Complications and prognostic factors in Vogt-Koyanagi-Harada disease","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0465","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1111\/aos.12127","article-title":"Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids","volume":"91","author":"Abu El-Asrar","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"2-3","key":"10.1016\/j.autrev.2016.04.001_bb0470","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10792-007-9062-9","article-title":"Prognostic factors in Vogt-Koyanagi-Harada disease","volume":"27","author":"Al-Kharashi","year":"2007","journal-title":"Int Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0475","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/09273948.2012.723780","article-title":"Vogt-Koyanagi-Harada disease in Thailand","volume":"20","author":"Yodmuang","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0480","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajo.2008.07.044","article-title":"Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore","volume":"147","author":"Chee","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0485","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1111\/aos.12648","article-title":"Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease","volume":"93","author":"Urzua","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0490","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/eye.2008.89","article-title":"Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease","volume":"23","author":"Lai","year":"2009","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0495","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/09273941003587541","article-title":"Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic vogt-koyanagi-harada disease","volume":"18","author":"Cuchacovich","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.autrev.2016.04.001_bb0500","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1111\/j.1755-3768.2012.02498.x","article-title":"The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease","volume":"90","author":"Abu El-Asrar","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0505","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archopht.1991.01080050096037","article-title":"Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome","volume":"109","author":"Rubsamen","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0510","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09273940500536766","article-title":"Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy","volume":"14","author":"Paredes","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.autrev.2016.04.001_bb0515","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0520","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ajo.2014.01.015","article-title":"Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease","volume":"157","author":"Hosoda","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0525","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajo.2006.02.049","article-title":"Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease","volume":"142","author":"Read","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.autrev.2016.04.001_bb0530","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/bjophthalmol-2014-306244","article-title":"Posterior subtenon triamcinolone acetonide injection as a primary treatment in eyes with acute Vogt-Koyanagi-Harada disease","volume":"99","author":"Hosoda","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0535","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ajo.2003.08.035","article-title":"Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome","volume":"137","author":"Andrade","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0540","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s10067-014-2623-1","article-title":"Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis","volume":"34","author":"Latronico","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2016.04.001_bb0545","first-page":"1423","article-title":"Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant","volume":"4","author":"Myung","year":"2010","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0550","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/09273940903267936","article-title":"Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease","volume":"17","author":"Khalifa","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.autrev.2016.04.001_bb0555","series-title":"Intraocular inflammation and uveitis. Basic and Clinical Science Course 2012-2013","author":"Moorthy","year":"2012"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0560","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00004397-200604620-00013","article-title":"Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use","volume":"46","author":"Kim","year":"2006","journal-title":"Int Ophthalmol Clin"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0565","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/09273940701624312","article-title":"The use of low-dose azathioprine in patients with Vogt-Koyanagi-Harada disease","volume":"15","author":"Kim","year":"2007","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0570","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/09273940600976938","article-title":"Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome","volume":"14","author":"Agarwal","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0575","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004397-200604620-00011","article-title":"Vogt-Koyanagi-Harada disease","volume":"46","author":"Andreoli","year":"2006","journal-title":"Int Ophthalmol Clin"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0580","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.clim.2008.12.007","article-title":"Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome","volume":"131","author":"Liu","year":"2009","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0585","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09273940600557001","article-title":"Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis","volume":"14","author":"Soheilian","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0590","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s10384-011-0092-5","article-title":"Chronic noninfectious uveitis associated with Vogt-Koyanagi-Harada disease treated with low-dose weekly systemic methotrexate","volume":"56","author":"Kondo","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.autrev.2016.04.001_bb0595","doi-asserted-by":"crossref","first-page":"b2480","DOI":"10.1136\/bmj.b2480","article-title":"Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study","volume":"339","author":"Kempen","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0600","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00055735-200312000-00014","article-title":"Use of immunosuppressive agents in uveitis","volume":"14","author":"Lustig","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0605","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0161-6420(01)00942-3","article-title":"Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation","volume":"109","author":"Goldstein","year":"2002","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.autrev.2016.04.001_bb0610","first-page":"401","article-title":"Intravenous immunoglobulin therapy in Vogt-Koyanagi-Harada syndrome","volume":"19","author":"Gonzalez-Delgado","year":"2004","journal-title":"Neurologia"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0615","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1212\/WNL.46.2.584","article-title":"Treatment of Vogt-Koyanagi-Harada syndrome with intravenous immunoglobulin","volume":"46","author":"Helveston","year":"1996","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.autrev.2016.04.001_bb0620","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1136\/bjo.2008.153981","article-title":"Efficacy of infliximab therapy in two patients with refractory Vogt-Koyanagi-Harada disease","volume":"93","author":"Niccoli","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.autrev.2016.04.001_bb0625","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/09273948.2013.775312","article-title":"Successful use of infliximab therapy in sight-threatening corticosteroid-resistant Vogt-Koyanagi-Harada disease","volume":"21","author":"Zmuda","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.autrev.2016.04.001_bb0630","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/09273940802204527","article-title":"Infliximab therapy for 2 patients with Vogt-Koyanagi-Harada syndrome","volume":"16","author":"Wang","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0635","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ophtha.2006.01.005","article-title":"Favorable response to high-dose infliximab for refractory childhood uveitis","volume":"113","author":"Kahn","year":"2006","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0640","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archophthalmol.2009.141","article-title":"Infliximab therapy for refractory uveitis: 2-year results of a prospective trial","volume":"127","author":"Suhler","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0645","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/09273941003739910","article-title":"Treatment of pediatric vogt-koyanagi-harada syndrome with infliximab","volume":"18","author":"Khalifa","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0650","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/jop.2008.0073","article-title":"Adalimumab therapy for refractory uveitis: a pilot study","volume":"24","author":"Callejas-Rubio","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0655","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/jop.2007.0104","article-title":"Adalimumab therapy for refractory uveitis: a pilot study","volume":"24","author":"Diaz-Llopis","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0660","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4321\/S0365-66912007000300003","article-title":"Adalimumab therapy for Vogt-Koyanagi-Harada syndrome","volume":"82","author":"Diaz Llopis","year":"2007","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"4","key":"10.1016\/j.autrev.2016.04.001_bb0665","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3928\/23258160-20140709-09","article-title":"Efficacy of adalimumab for pediatric Vogt-Koyanagi-Harada syndrome","volume":"45","author":"Jeroudi","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"4","key":"10.1016\/j.autrev.2016.04.001_bb0670","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12348-011-0027-9","article-title":"Rituximab in refractory Vogt-Koyanagi-Harada disease","volume":"1","author":"Dolz-Marco","year":"2011","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.autrev.2016.04.001_bb0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14397595.2015.1071234","article-title":"Rituximab for sight-threatening refractory pediatric Vogt-Koyanagi-Harada disease","author":"Umran","year":"2015","journal-title":"Mod Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0680","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/bjo.2009.177279","article-title":"Vascular endothelial growth factor inhibition in uveitis: a systematic review","volume":"95","author":"Gulati","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0685","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0002-9394(01)01103-5","article-title":"Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema","volume":"132","author":"Fine","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0690","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1177\/112067210701700611","article-title":"Increased vascular endothelial growth factor levels in aqueous humor and serum of patients with quiescent uveitis","volume":"17","author":"Paroli","year":"2007","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0695","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.preteyeres.2008.11.005","article-title":"Therapeutic monoclonal antibodies in ophthalmology","volume":"28","author":"Rodrigues","year":"2009","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0700","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10384-008-0600-4","article-title":"Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome","volume":"53","author":"Wu","year":"2009","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0705","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3129\/i09-144","article-title":"Intravitreal bevacizumab injection in a 14-year-old Vogt-Koyanagi-Harada patient with choroidal neovascular membrane","volume":"44","author":"Raffa","year":"2009","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0710","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1755-3768.2010.02046.x","article-title":"Intravitreal bevacizumab as first local treatment for uveitis-related choroidal neovascularization: long-term results","volume":"89","author":"Julian","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.autrev.2016.04.001_bb0715","first-page":"747648","article-title":"The use of intravitreal ranibizumab for choroidal neovascularization associated with vogt-koyanagi-harada syndrome","author":"Kolomeyer","year":"2011","journal-title":"Case Rep Med"},{"key":"10.1016\/j.autrev.2016.04.001_bb0720","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2147\/OPTH.S34294","article-title":"Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization","volume":"6","author":"Mansour","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0725","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4103\/0301-4738.103795","article-title":"Management of recurrent inflammatory choroidal neovascular membrane secondary to Vogt-Koyanagi-Harada syndrome, using combined intravitreal injection of bevacizumab and triamcinolone acetate","volume":"60","author":"Pai","year":"2012","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0730","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00417-010-1477-8","article-title":"Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease","volume":"249","author":"Park","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2016.04.001_bb0735","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/IAE.0b013e3182a0e446","article-title":"Treatment of persistent serous retinal detachment in Vogt-Koyanagi-Harada syndrome with intravitreal bevacizumab during the systemic steroid treatment","volume":"34","author":"Reibaldi","year":"2014","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.autrev.2016.04.001_bb0740","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2893.2003.00456.x","article-title":"Vogt-Koyanagi-Harada disease associated with interferon alpha-2b\/ribavirin combination therapy","volume":"10","author":"Sylvestre","year":"2003","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.autrev.2016.04.001_bb0745","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3350\/kjhep.2011.17.1.61","article-title":"Vogt-Koyanagi-Harada disease occurring during pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C","volume":"17","author":"Lim","year":"2011","journal-title":"Korean J Hepatol"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0750","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10792-010-9357-0","article-title":"Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection","volume":"30","author":"Al-Muammar","year":"2010","journal-title":"Int Ophthalmol"},{"issue":"5","key":"10.1016\/j.autrev.2016.04.001_bb0755","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ajo.2005.06.020","article-title":"Vogt-Koyanagi-Harada disease in patients with chronic hepatitis C","volume":"140","author":"Touitou","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2016.04.001_bb0760","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.jinf.2005.05.005","article-title":"Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection","volume":"52","author":"Papastathopoulos","year":"2006","journal-title":"J Infect"},{"issue":"11","key":"10.1016\/j.autrev.2016.04.001_bb0765","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00535-004-1452-4","article-title":"Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C","volume":"39","author":"Kasahara","year":"2004","journal-title":"J Gastroenterol"},{"issue":"22","key":"10.1016\/j.autrev.2016.04.001_bb0770","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.3748\/wjg.v13.i22.3137","article-title":"Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C","volume":"13","author":"Sene","year":"2007","journal-title":"World J Gastroenterol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216300787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216300787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T16:12:10Z","timestamp":1718467930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216300787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":154,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1568997216300787"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.04.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vogt\u2013Koyanagi\u2013Harada syndrome: Perspectives for immunogenetics, multimodal imaging, and therapeutic options","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}